V

Veerhealth Care Limited

VEERHEALTH
Market snapshot · 2026-08-11 13:22 UTC

46.50

+₹0.21 (+0.45%)

MARKET CAP

₹92.99 Cr

STOCK P/E

172.2x

52W HIGH

₹46.85

52W LOW

₹16.70

BOOK VALUE

₹11.67

EPS

₹0.27

ROE

2.41%

SECTOR

Health Care

DEBT/EQUITY

19.96

VOLUME

1.18L

P/B RATIO

3.99x

PEG RATIO

Sector

Health Care

Themes

Pharmaceuticals
₹44.10₹37.44₹30.79₹24.13₹17.47VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Forecast

Analyst targets, estimate history, and probabilistic forward ranges for VEERHEALTH.

Coverage check

Price Forecast

Current
₹46.85
High Target
Median Target
Low Target
Now₹46.85Aug '25Now12M Target
Price history (1Y)
Analyst target range

Revenue Forecast

₹ Cr
Mar '26Current₹17.0
Sep 2026 ETrend estimate range
High₹6.5Base₹6.0Low₹5.5
Jun '25: ₹4.0 · Sep '25: ₹4.0 · Dec '25: ₹7.0 · Mar '26: ₹17.0 · Sep '26: ₹6.0 · Dec '26: ₹10.5
Jun '25Sep '25Dec '25Mar '26Sep '26 EDec '26 E4.04.07.017.06.010.5
PastCurrentTrend estimate: Low / Base / High

EPS Forecast

₹ / share
Mar '26Current₹-0.18
Sep 2026 ETrend estimate range
High₹0.16Base₹0.14Low₹0.12
Jun '25: ₹0.12 · Sep '25: ₹0.13 · Dec '25: ₹0.20 · Mar '26: ₹-0.18 · Sep '26: ₹0.14 · Dec '26: ₹0.22
Jun '25Sep '25Dec '25Mar '26Sep '26 EDec '26 E0.120.130.20-0.180.140.22
PastCurrentTrend estimate: Low / Base / High
Analyst price target unavailable from FMP/yfinance. Analyst recommendation consensus unavailable from FMP/yfinance. Analyst pillar unavailable from FMP/yfinance.
Market Intelligence

Multi-factor synthesis of 5 key dimensions

Overall Outlook
Cautious
23%
Analyst Consensus
Unavailable

Analyst coverage unavailable

Mean upsideNot available

Fundamentals

Weakening

Fundamentals institutional score is 12 using EVA spread proxy -9.6%; accruals ratio 0.65; growth durability 33.3.

Valuation

Premium valuation

Valuation institutional score is 0 using relative multiple z-scores where peer dispersion is available.

Analyst Consensus

Unavailable

No usable analyst target or recommendation data was available.

Technical Structure

Unavailable

This data source has not been supplied for the decision payload.

Market Sentiment

Neutral backdrop

Recent news flow is balanced or not decisive enough to tilt the tape. Based on 8 recent ticker-linked news items.

Signal Summary

Market intelligence remains Cautious. market sentiment provide support, while fundamentals and valuation remain considerations.

Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.

Fundamentals WeakeningValuation Premium valuationMarket Sentiment Neutral backdrop

Key Data Points

Mean Target PriceUnavailable
Mean UpsideNot available
Technical ScoreUnavailable
Fundamental Score13%
Data CoverageMedium

Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.

Valuation Metrics

Trading 131.6% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +4.85). Confidence: 74%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Strongly Overvalued

5Y Average

60.80

Current

173.52

Overvalued

81.31

Undervalued

67.66

EV/EBITDA
Strongly Overvalued

5Y Average

10.21

Current

29.15

Overvalued

12.72

Undervalued

6.09

P/S
Strongly Overvalued

5Y Average

0.99

Current

2.81

Overvalued

1.13

Undervalued

0.84

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹17 CrMar 2026

Latest net profit

₹0.00 CrMar 2026

Latest EPS

₹-0.18Mar 2026

Net margin

2.3%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26-14.0%-7.0%0.0%7.0%14.0%0.00 Cr5.00 Cr10 Cr15 Cr20 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr5.00 Cr10 Cr15 Cr20 Cr₹-0₹-0₹0₹0₹0
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestProfitbefore taxTax & otherNet Profit0.00 Cr5.00 Cr10 Cr15 Cr20 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2025Sep 2025Mar 2026-15 Cr0.00 Cr15 Cr30 Cr45 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

Sales

₹17 Cr

+198.2%

Net Profit

₹-0 Cr

-256.2%

EBITDA

₹1 Cr

+135.9%

EPS

₹-0.18

-260.0%
MetricMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales644717
Expenses654616
Operating Profit-0-0010
OPM %-7.63%-7.02%5.45%12.17%2.28%
Other Income010-00
Interest00000
Depreciation00000
Profit before tax-00000
Tax %25.28%0.0%26.3%18.19%296.28%
Net Profit-0000-0
EPS in Rs-0.050.120.130.20-0.18

All values in ₹ Crores unless otherwise stated. Source: Company filings.

Shareholding Pattern

HolderMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters31.50%31.50%31.50%31.50%31.50%
Public58.35%57.92%56.97%55.12%54.27%
Others10.15%10.58%11.53%13.38%14.23%
Mar 2026
Promoters
Public
Others